The funding is expected to enable Tesis to increase its production capability and clinical support and allow the company to move ahead with clinical initiatives for several of its proprietary products currently going through clinical validation.
This is Tesis’ first external financing since it started in early 2020. The new sum brings the company’s total to-date funding to $35 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.